Is my portfolio
One Report to Answer all your Questions!
Natco Pharma Ltd.
BSE: 524816 | NSE: NATCOPHARM
Small Cap | Pharmaceuticals & Drugs
917.90
3.05 (0.33%) Natco Pharma submits analyst meet intimation
Date: 10-02-2025Further to earlier intimation dated 3rd February, 2025, Natco Pharma has informed that the Earnings Call with Investors / Analysts on Thursday, the 13th February, 2025 at 11:00 AM IST has been preponed to Thursday, the 13th February, 2025 at 10:00 AM IST to discuss the Unaudited Financial Results of the Company for the quarter ended 31st December, 2024.
The above information is a part of company’s filings submitted to BSE.